Skye Bioscience to Participate in Upcoming Investment and Medical Conferences

About this update from Skye Bioscience, Inc.

[{"type":"image","alt":"Skye Bioscience, Inc.","displaySize":"","headline":null,"caption":"Skye Bioscience, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":141,"url":"https://media.zenfs.com/en/globenewswire.com/90c497d694309d41a1d6fa12ddb2a61c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/7pwAl2G8ZGCyG39CbcNdmw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE5NztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/90c497d694309d41a1d6fa12ddb2a61c","width":300,"height":141}},"lazy":false},{"type":"text","content":"SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that it will participate in the following upcoming investment and medical conferences:","length":329,"tagName":"p"},{"type":"text","content":"Investment Conferences","length":22,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Cantor Global Healthcare Conference (New York)Fireside Chat Sept. 5 8:00 am ET + 1x1 meetings","length":94,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":94,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"H.C. Wainwright Global Investment Conference (New York)Presentation Sept. 8 3:30 pm ET + 1x1 meetings","length":102,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":102,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Morgan Stanley Global Healthcare Conference (New York)Fireside Chat Sept. 10 7:00 am ET + 1x1 meetings","length":103,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":103,"olType":false},{"type":"text","content":"Medical/Scientific Conferences","length":30,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Obesity Science & Innovation (Boston)Keynote Panel Sept. 16 9:10 am ETTitle: Pipeline priorities - exploring leading and emerging targets shaping the future of obesity therapeutics","length":186,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":186,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"European Association for the Study of Diabetes Annual Meeting (EASD) (Vienna, Austria)Oral Presentation Sept. 19 10:15 am CETTitle: A multiple dose study to ev...

More updates from Skye Bioscience, Inc.